Cite
HARVARD Citation
Tolba, M. et al. (2018). Immunotherapy, an evolving approach for the management of triple negative breast cancer: Converting non-responders to responders. Critical reviews in oncology/hematology. pp. 202-207. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tolba, M. et al. (2018). Immunotherapy, an evolving approach for the management of triple negative breast cancer: Converting non-responders to responders. Critical reviews in oncology/hematology. pp. 202-207. [Online].